ACC

American College of Cardiology, #ACC18

Most of the big stories March 2018 were the late-breaking trial presentations at the American College of Cardiology (ACC) meeting during the month.

Feature | April 02, 2018 | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

Blog | March 26, 2018

I have been looking for new ways to show readers interesting things I find during the medical conferences I attend,...

An example of the new generation of inexpensive, wearable cardiac monitors. This is the Cardea Solo device. #ACC18

An example of the new generation of inexpensive, wearable cardiac monitors that are seeing increased usage. This is the Cardea Solo device. After the monitoring period is over, the wearable patch is torn open to retrieve a data pod that is inserted into a reader to download the data. The software automatically creates reports based on the data, complete with waveforms for various cardiac measures.

Blog | ACC | March 29, 2018

The show floor at the American College of Cardiology (ACC) 2018 meeting included numerous vendors offering small,...

Videos | Cath Lab | March 27, 2018

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional...

Videos | Intravascular Imaging | March 27, 2018

A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular...

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell

There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American...

Videos | Cardiac Diagnostics | March 26, 2018

James Januzzi, M.D., Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, and director of the...

Videos | Heart Failure | March 23, 2018

David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit,...

Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018

March 23, 2018 — Patients with foot ulcers or gangrene who received the...

Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018

March 22, 2018 — The experimental ...

Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018

March 21, 2018 — Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (...

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018

March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help...

Videos | ACC | March 21, 2018

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018...

Videos | Womens Cardiovascular Health | March 21, 2018

A discussion with Doreen DeFaria Yeh, M.D., associate director, Massachusetts General Hospital Adult Congenital...

Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018

March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily...

Overlay Init